dan 2163 has been researched along with sertraline in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (55.56) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Amore, M; Jori, MC | 1 |
Bogetto, F; Gandolfo, S; Maina, G; Vitalucci, A | 1 |
Croissant, B; Heinz, A; Hermann, D; Mann, K | 1 |
Goulia, P; Hyphantis, T; Mavreas, V; Pappas, D; Peritogiannis, V | 1 |
Mendhekar, DN | 1 |
Abaitua, I; Alonso-Ferreira, V; Hens, MJ; Posada de la Paz, M; Villaverde-Hueso, A | 1 |
D'iakonov, AL; Lobanova, IV | 1 |
Gangadhar, P; Rafeeque, PA; Sreeraj, VS; Uvais, NA | 1 |
2 trial(s) available for dan 2163 and sertraline
Article | Year |
---|---|
Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group study.
Topics: Adolescent; Adult; Aged; Amisulpride; Antidepressive Agents; Antipsychotic Agents; Depressive Disorder; Double-Blind Method; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Sulpiride | 2001 |
Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study.
Topics: Amisulpride; Antipsychotic Agents; Burning Mouth Syndrome; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method; Sulpiride; Treatment Outcome | 2002 |
7 other study(ies) available for dan 2163 and sertraline
Article | Year |
---|---|
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Serotonin reuptake inhibitor provoked recurrence of alcohol hallucinosis--remission with additive amisulpride medication. A case report.
Topics: Alcohol Withdrawal Delirium; Amisulpride; Antipsychotic Agents; Drug Therapy, Combination; Humans; Male; Middle Aged; Recurrence; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sertraline; Sulpiride | 2004 |
Amenorrhea after sertraline introduction in an amisulpride-treated patient with undiagnosed polycystic ovary disease.
Topics: Adult; Amenorrhea; Amisulpride; Antipsychotic Agents; Depression; Drug Interactions; Female; Humans; Hyperprolactinemia; Polycystic Ovary Syndrome; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulpiride | 2007 |
Hyperpigmentation with amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Hyperpigmentation; Obsessive-Compulsive Disorder; Photosensitivity Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulpiride | 2009 |
Cost-effectiveness analysis of burning mouth syndrome therapy.
Topics: Amisulpride; Antidepressive Agents; Burning Mouth Syndrome; Clonazepam; Cost-Benefit Analysis; Decision Trees; Dental Care; Drug Costs; Health Care Costs; Humans; Paroxetine; Sertraline; Sulpiride | 2012 |
[The comparative study on the efficacy of the combination of serotonin reuptake inhibitor antidepressants and antipsychotics in the treatment of recurrent depressive disorders].
Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Olanzapine; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulpiride; Treatment Outcome; Young Adult | 2012 |
Neuroleptic malignant syndrome (NMS) associated with amisulpride and sertraline use: A case report and discussion.
Topics: Aged; Amisulpride; Antipsychotic Agents; Depressive Disorder; Female; Humans; Neuroleptic Malignant Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline | 2019 |